Charles Schwab Investment Management Inc Impel Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.83 - $10.12 $83,689 - $145,272	-14,355 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.86 - $9.85 $416 - $699	71 Added 0.5%	14,355 $92,000
Q3 2021 Nov 16, 2021	BUY	$8.38 - $26.13 $24,058 - $75,019	2,871 Added 25.16%	14,284 $174,000
Q2 2021 Aug 16, 2021	BUY	$7.33 - $15.2 $83,657 - $173,477	11,413 New	11,413 $102,000

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.